One of the main features in the Smart Watch Apple Watch Series 4 is a feature electrocardiogram and well-known acronym in the name of the ECG. When Apple announced about this smart watch, it said that this feature got the authentication authority, the food and Drug Administration well-known acronym in the name of the FDA, which allowed her to announce it at this event. However, it seems that she was close to no advertising for this feature.
According to a new report released recently from the website Fast Company, it turns out that Apple did not get approval from the food and Drug Administration before the announcement of the Smart Watch Apple Watch Series 4, we are not talking about a waiting period stretches for days or weeks, but for 24 hours. This means that during the four hours twenty that ever happened to the official announcement of the former, there was uncertainty about whether Apple should know about this feature is legal or not, although we all know how was it in the end.
However, it should be noted that the electrocardiogram at the Smart Watch Apple Watch Series 4 will not be available from the outset to the users. Instead, it is expected that up later. Should also point out that the EKG in the Smart Watch Apple Watch Series 4 will not be available in other markets, perhaps because Apple need to obtain the approval of regulatory bodies on such a feature just like what you did with the food and Drug Administration ( FDA ) in the United States of America.
Hope it doesn’t take a long time because the EKG represents one of the main features of the Smart Watch Apple Watch Series 4, although it now seems that pre-orders on this smart watch new was higher than expectations.
The post Apple was close to non-declaration of the feature of the ECG for the Smart Watch Apple Watch Series 4 appeared first on electronic.